A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
Clinical trial NCT01570296 · COMPLETED
Trial details
- NCT number
- NCT01570296
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-03
- Primary completion
- 2016-02-22
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.